A 65-year-old man on aspirin for chronic coronary disease asks about adding rivaroxaban 2.5 mg BID to reduce CV events. He has no high bleeding risk. ...

Question

A 65-year-old man on aspirin for chronic coronary disease asks about adding rivaroxaban 2.5 mg BID to reduce CV events. He has no high bleeding risk. Which statement is accurate?

Accepted Answer

Low-dose rivaroxaban plus aspirin can reduce MACE in selected stable CAD/PAD patients

Answer

Rivaroxaban 20 mg daily is indicated with aspirin for CAD

Answer

Dual therapy is contraindicated in all patients

Answer

Only clopidogrel with aspirin reduces risk

Answer

Anticoagulation replaces the need for statin therapy

us-abim MCQ (SBA): CAD-Dual-Pathway Inhibition

A 65-year-old man on aspirin for chronic coronary disease asks about adding rivaroxaban 2.5 mg BID to reduce CV events. He has no high bleeding risk. Which statement is accurate?